SCHEMBL4758150

SCHEMBL4758150

COc1ccccc1C(=O)NC(C)Cc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.63
ALDH1A1 P00352 1/20 0.63
TP53 P04637 1/20 0.61
GLA P06280 1/20 0.61
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
CTSD P07339 1/20 0.56
KDM4E B2RXH2 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CNR2 P34972 1/20 0.53
LMNA P02545 2/20 0.53
KCNA3 P22001 1/20 0.53
CAPN1 P07384 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4758147 1.00 HPGD (0.63) HPGDALDH1A1TP53GLANPC1
SCHEMBL14976802 0.88 MEN1 (0.61) HPGDALDH1A1TP53GLANPC1
SCHEMBL10330508 0.85 HPGD (0.62) HPGDALDH1A1TP53GLANPC1
SCHEMBL6368355 0.84 ALDH1A1 (0.62) HPGDALDH1A1TP53GLAMEN1
SCHEMBL6368357 0.84 ALDH1A1 (0.62) HPGDALDH1A1TP53GLAMEN1
SCHEMBL29619793 0.84 ALDH1A1 (0.62) HPGDALDH1A1TP53GLAMEN1
SCHEMBL14819905 0.83 HPGD (0.58) HPGDALDH1A1TP53GLANPC1
SCHEMBL28613885 0.83 HPGD (0.58) HPGDALDH1A1TP53GLARAB9A
SCHEMBL24863013 0.82 CAPN1 (0.66) HPGDALDH1A1TP53GLAL3MBTL1
SCHEMBL18893131 0.81 L3MBTL1 (0.74) HPGDALDH1A1TP53GLANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009001214-A2 THIENO[2,3-D]PYRIMIDIN-4(3H)-ONE, ISOXAZOLO[5,4-D]PYRIMIDIN-4(5H)-ONE AND ISOTHIAZOLO[5,4-D]PYRIMIDIN-4(5H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2008-12-31 WO disclosed